New heat treatment could zap small breast tumors without surgery
NCT ID NCT04389216
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a device that uses heat (radiofrequency ablation) to destroy small breast tumors (less than 2 cm). Thirty women with early-stage breast cancer received the treatment to see if it could safely eliminate the tumor. The goal was to find a less invasive option than standard surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiofrequency ablation device (cool-tip electrode)
What this could lead to
If successful, this could offer a less invasive treatment option for small breast tumors, potentially reducing the need for surgery.
What could go wrong
This was a small, early-stage study with only 30 participants. The results may not apply to all breast cancer patients, and there is a risk of incomplete tumor destruction or side effects from the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Hospital del Mar
Barcelona, Barcelona, 08003, Spain